<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36379135</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>30</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-5883</ISSN><JournalIssue CitedMedium="Internet"><Volume>443</Volume><PubDate><Year>2022</Year><Month>Dec</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of the neurological sciences</Title><ISOAbbreviation>J Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Life stressors significantly impact long-term outcomes and post-acute symptoms 12-months after COVID-19 hospitalization.</ArticleTitle><Pagination><StartPage>120487</StartPage><MedlinePgn>120487</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jns.2022.120487</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-510X(22)00349-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">Limited data exists evaluating predictors of long-term outcomes after hospitalization for COVID-19.</AbstractText><AbstractText Label="METHODS">We conducted a prospective, longitudinal cohort study of patients hospitalized for COVID-19. The following outcomes were collected at 6 and 12-months post-diagnosis: disability using the modified Rankin Scale (mRS), activities of daily living assessed with the Barthel Index, cognition assessed with the telephone Montreal Cognitive Assessment (t-MoCA), Neuro-QoL batteries for anxiety, depression, fatigue and sleep, and post-acute symptoms of COVID-19. Predictors of these outcomes, including demographics, pre-COVID-19 comorbidities, index COVID-19 hospitalization metrics, and life stressors, were evaluated using multivariable logistic regression.</AbstractText><AbstractText Label="RESULTS">Of 790 COVID-19 patients who survived hospitalization, 451(57%) completed 6-month (N&#xa0;=&#xa0;383) and/or 12-month (N&#xa0;=&#xa0;242) follow-up, and 77/451 (17%) died between discharge and 12-month follow-up. Significant life stressors were reported in 121/239 (51%) at 12-months. In multivariable analyses, life stressors including financial insecurity, food insecurity, death of a close contact and new disability were the strongest independent predictors of worse mRS, Barthel Index, depression, fatigue, and sleep scores, and prolonged symptoms, with adjusted odds ratios ranging from 2.5 to 20.8. Other predictors of poor outcome included older age (associated with worse mRS, Barthel, t-MoCA, depression scores), baseline disability (associated with worse mRS, fatigue, Barthel scores), female sex (associated with worse Barthel, anxiety scores) and index COVID-19 severity (associated with worse Barthel index, prolonged symptoms).</AbstractText><AbstractText Label="CONCLUSIONS">Life stressors contribute substantially to worse functional, cognitive and neuropsychiatric outcomes 12-months after COVID-19 hospitalization. Other predictors of poor outcome include older age, female sex, baseline disability and severity of index COVID-19.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Frontera</LastName><ForeName>Jennifer A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Departments of Neurology, New York University Grossman School of Medicine, New York, NY, USA. Electronic address: jennifer.frontera@nyulangone.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabadia</LastName><ForeName>Sakinah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Departments of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Dixon</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York Presbyterian, Columbia Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Havenon</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Yale University School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yaghi</LastName><ForeName>Shadi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brown University School of Medicine, Providence, RI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lewis</LastName><ForeName>Ariane</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Departments of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lord</LastName><ForeName>Aaron S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Departments of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melmed</LastName><ForeName>Kara</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Departments of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thawani</LastName><ForeName>Sujata</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Departments of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balcer</LastName><ForeName>Laura J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Departments of Neurology, New York University Grossman School of Medicine, New York, NY, USA; Population Health, New York University Grossman School of Medicine, New York, NY, USA; Ophthalmology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wisniewski</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Departments of Neurology, New York University Grossman School of Medicine, New York, NY, USA; Pathology, New York University Grossman School of Medicine, New York, NY, USA; Psychiatry, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galetta</LastName><ForeName>Steven L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Departments of Neurology, New York University Grossman School of Medicine, New York, NY, USA; Ophthalmology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>NYU Neurology COVID-19 Study Team</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U24 NS113844</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066512</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG077422</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG060882</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001863</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 HL161847</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Neurol Sci</MedlineTA><NlmUniqueID>0375403</NlmUniqueID><ISSNLinking>0022-510X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anxiety</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cognition</Keyword><Keyword MajorTopicYN="N">Depression</Keyword><Keyword MajorTopicYN="N">Disability</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Long-hauler</Keyword><Keyword MajorTopicYN="N">Outcomes</Keyword><Keyword MajorTopicYN="N">Post-COVID syndrome</Keyword><Keyword MajorTopicYN="N">Post-acute sequelae of COVID</Keyword><Keyword MajorTopicYN="N">Predictors</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest Potential conflict of interest: JAF receives funding for the following COVID-19-related grants: NIH/NIA R01AG077422, NIH/NINDS 3U24NS11384401S1, NIH/NHLBI 1OT2HL161847-01; LJB and ST receive funding for the following COVID-19-related grant: NIH/NHLBI 1OT2HL161847-01. TW receives funding for the following COVID-19 related grant: NIH/NIA R01AG077422. JAF and TW have received funding for the COVID-19 related grant: NIH/NIA 3P30AG066512-01S1. AdH, SY, SS, DY, AL, ASL, KM, and SLG do not report any relevant conflicts of interest.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Agarwal</LastName><ForeName>Shashank</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Andino</LastName><ForeName>Andres</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Arena</LastName><ForeName>Vito</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Baskharoun</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bauman</LastName><ForeName>Kristie</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bell</LastName><ForeName>Lena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Berger</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bhagat</LastName><ForeName>Dhristie</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bokhari</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bondi</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Canizares</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Chervinsky</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Czeisler</LastName><ForeName>Barry M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dygert</LastName><ForeName>Levi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Fang</LastName><ForeName>Taolin</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Flusty</LastName><ForeName>Brent</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Friedman</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Friedman</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Fuchs</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Granger</LastName><ForeName>Andre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gratch</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gurin</LastName><ForeName>Lindsey</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gutman</LastName><ForeName>Josef</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hasanaj</LastName><ForeName>Lisena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Holmes</LastName><ForeName>Manisha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Horng</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Huang</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Medical Informatics, NYU Langone Hospitals, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ishii</LastName><ForeName>Haruki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Jauregui</LastName><ForeName>Ruben</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ji</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kahn</LastName><ForeName>D Ethan</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Koch</LastName><ForeName>Ethan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Krieger</LastName><ForeName>Penina</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kvernland</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lalchan</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lillemoe</LastName><ForeName>Kaitlyn</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lin</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Liu</LastName><ForeName>Susan B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Madhavan</LastName><ForeName>Maya</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Medicherla</LastName><ForeName>Chaitanya</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Millar-Vernetti</LastName><ForeName>Patricio</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Morgan</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Olivera</LastName><ForeName>Anlys</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Omari</LastName><ForeName>Mirza</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Park</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Patel</LastName><ForeName>Palak</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ristic</LastName><ForeName>Milan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rosenthal</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sonson</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Snyder</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Stainman</LastName><ForeName>Rebecca S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sunwoo</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Talmasov</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tamimi</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Thomas</LastName><ForeName>Betsy</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Valdes</LastName><ForeName>Eduard</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zhou</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zhu</LastName><ForeName>Yingrong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>15</Day><Hour>18</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36379135</ArticleId><ArticleId IdType="pmc">PMC9637014</ArticleId><ArticleId IdType="doi">10.1016/j.jns.2022.120487</ArticleId><ArticleId IdType="pii">S0022-510X(22)00349-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Frontera J.A., Yang D., Medicherla C., et al. Trajectories of neurologic recovery 12 months after hospitalization for COVID-19: a prospective longitudinal study. Neurology. 2022;Jul 5;99(1):e33-e45</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9259089</ArticleId><ArticleId IdType="pubmed">35314503</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell M.L., Catalfamo C.J., Farland L.V., et al. Post-acute sequelae of COVID-19 in a non-hospitalized cohort: results from the Arizona CoVHORT. PLoS One. 2021;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8336814</ArticleId><ArticleId IdType="pubmed">34347785</ArticleId></ArticleIdList></Reference><Reference><Citation>Misra S., Kolappa K., Prasad M., et al. Frequency of neurologic manifestations in COVID-19: a systematic review and meta-analysis. Neurology. 2021;97:e2269&#x2013;e2281.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8665434</ArticleId><ArticleId IdType="pubmed">34635561</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A.E., et al. Short-term and long-term rates of Postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw. Open. 2021;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Maestre-Muniz M.M., Arias A., Mata-Vazquez E., et al. Long-term outcomes of patients with coronavirus disease 2019 at one year after hospital discharge. J. Clin. Med. 2021:10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8269002</ArticleId><ArticleId IdType="pubmed">34209085</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Lewis A., Melmed K., et al. Prevalence and predictors of prolonged cognitive and psychological symptoms following COVID-19 in the United States. Front. Aging Neurosci. 2021:13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8326803</ArticleId><ArticleId IdType="pubmed">34349633</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Gonzalez A., Araujo-Ameijeiras A., Fernandez-Villar A., Crespo M., Poveda E., Cohort C-otGSHRI Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study. Sci. Rep. 2022;12:3369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8888560</ArticleId><ArticleId IdType="pubmed">35233035</ArticleId></ArticleIdList></Reference><Reference><Citation>Desgranges F., Tadini E., Munting A., et al. PostCOVID19 syndrome in outpatients: a cohort study. J. Gen. Intern. Med. 2022;Jun;37(8):1943-1952</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8939498</ArticleId><ArticleId IdType="pubmed">35319081</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Simon N.M. Bridging knowledge gaps in the diagnosis and management of neuropsychiatric sequelae of COVID-19. JAMA Psychiatry. 2022;Aug 1;79(8):811-817</Citation><ArticleIdList><ArticleId IdType="pubmed">35767287</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Sabadia S., Lalchan R., et al. A prospective study of neurologic disorders in hospitalized patients with COVID-19 in new York City. Neurology. 2021;96:e575&#x2013;e586.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7905791</ArticleId><ArticleId IdType="pubmed">33020166</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Yang D., Lewis A., et al. A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. J. Neurol. Sci. 2021;426</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8113108</ArticleId><ArticleId IdType="pubmed">34000678</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdes E., Fuchs B., Morrison C., et al. Demographic and social determinants of cognitive dysfunction following hospitalization for COVID-19. J. Neurol. Sci. 2022;120146</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8739793</ArticleId><ArticleId IdType="pubmed">35031121</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent J.L., Moreno R., Takala J., et al. The SOFA (Sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on Sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707&#x2013;710.</Citation><ArticleIdList><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>van Swieten J.C., Koudstaal P.J., Visser M.C., Schouten H.J., van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604&#x2013;607.</Citation><ArticleIdList><ArticleId IdType="pubmed">3363593</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahoney F.I., Barthel D.W. Functional evaluation: the Barthel index. Md State Med. J. 1965;14:61&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">14258950</ArticleId></ArticleIdList></Reference><Reference><Citation>Pendlebury S.T., Welch S.J., Cuthbertson F.C., Mariz J., Mehta Z., Rothwell P.M. Telephone assessment of cognition after transient ischemic attack and stroke: modified telephone interview of cognitive status and telephone Montreal cognitive assessment versus face-to-face Montreal cognitive assessment and neuropsychological battery. Stroke. 2013;44:227&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5593099</ArticleId><ArticleId IdType="pubmed">23138443</ArticleId></ArticleIdList></Reference><Reference><Citation>Cella D., Lai J.S., Nowinski C.J., et al. Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology. Neurology. 2012;78:1860&#x2013;1867.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3369516</ArticleId><ArticleId IdType="pubmed">22573626</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuro-QoL Neuro-QoL Reference Populations. 2021. https://www.healthmeasures.net/score-and-interpret/interpret-scores/neuro-qol/reference-populations</Citation></Reference><Reference><Citation>Rossetti H.C., Lacritz L.H., Cullum C.M., Weiner M.F. Normative data for the Montreal cognitive assessment (MoCA) in a population-based sample. Neurology. 2011;77:1272&#x2013;1275.</Citation><ArticleIdList><ArticleId IdType="pubmed">21917776</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC Post-COVID Conditions [online] 2022. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html Available at:</Citation></Reference><Reference><Citation>WHO Global COVID-19 Clinical Platform Caser Report Form (CRF) for Post COVID Condition [online] 2022. https://www.who.int/publications/i/item/global-covid-19-clinical-platform-case-report-form-(crf)-for-post-covid-conditions-(post-covid-19-crf-) Available at:</Citation></Reference><Reference><Citation>Frontera J.A., Thorpe L.E., Simon N.M., et al. Post-acute sequelae of COVID-19 symptom phenotypes and therapeutic strategies: a prospective, observational study. PLoS One. 2022;17</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9521913</ArticleId><ArticleId IdType="pubmed">36174032</ArticleId></ArticleIdList></Reference><Reference><Citation>Leigh A.E., McCall J., Burke R.V., Rome R., Raines A.M. Predictors of functional dependence after COVID-19: a retrospective examination among veterans. Am. J. Phys. Med. Rehabil. 2021;100:34&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">33048890</ArticleId></ArticleIdList></Reference><Reference><Citation>Boari G.E.M., Chiarini G., Bonetti S., et al. Prognostic factors and predictors of outcome in patients with COVID-19 and related pneumonia: a retrospective cohort study. Biosci. Rep. 2020;40</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7724688</ArticleId><ArticleId IdType="pubmed">33201172</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Guzman P.N., Daunt A., Mukherjee S., et al. Clinical characteristics and predictors of outcomes of hospitalized patients with coronavirus disease 2019 in a multiethnic London National Health Service Trust: a retrospective cohort study. Clin. Infect. Dis. 2021;73:e4047&#x2013;e4057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454410</ArticleId><ArticleId IdType="pubmed">32766823</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Luciano S., Geddes J.R., Husain M., Harrison P.J. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbarialiabad H., Taghrir M.H., Abdollahi A., et al. Long COVID, a comprehensive systematic scoping review. Infection. 2021;Dec;49(6):1163-1186</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8317481</ArticleId><ArticleId IdType="pubmed">34319569</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi M.S., Omrani O.A., Fawzy N.A., et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin. Microbiol. Infect. 2022;28:657&#x2013;666.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight D.R.T., Munipalli B., Logvinov I.I., et al. Perception, prevalence, and prediction of severe infection and post-acute sequelae of COVID-19. Am J Med Sci. 2022;Apr;363(4):295-304</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8743283</ArticleId><ArticleId IdType="pubmed">35016849</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q., Xu M., Li J., et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-Centre longitudinal study. Clin. Microbiol. Infect. 2021;27:89&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Capin J.J., Wilson M.P., Hare K., et al. Prospective telehealth analysis of functional performance, frailty, quality of life, and mental health after COVID-19 hospitalization. BMC Geriatr. 2022;22:251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8956362</ArticleId><ArticleId IdType="pubmed">35337276</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F., Tomasoni D., Falcinella C., et al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin. Microbiol. Infect. 2022;28 611 e619&#x2013;611 e616.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Kambhampati N.T., Chithira Pillai M.G., Ts D., Moni M. Assessment of post-Covid symptoms in Covid-19 recovered patients: a prospective cohort study in a tertiary Care Centre of South India. J. Assoc. Physicians India. 2022;70:11&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">35443500</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorent N., Vande Weygaerde Y., Claeys E., et al. Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge. ERJ Open Res. 2022:8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8994962</ArticleId><ArticleId IdType="pubmed">35415186</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M., Palese A., Venturini M., et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin. Microbiol. Infect. 2021;27:1507&#x2013;1513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M., Elliott J., Chadeau-Hyam M., et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat. Commun. 2022;13:1957.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon N.R., Jauslin A.S., Rueegg M., et al. Association of Frailty with adverse outcomes in patients with suspected COVID-19 infection. J. Clin. Med. 2021:10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8199640</ArticleId><ArticleId IdType="pubmed">34199572</ArticleId></ArticleIdList></Reference><Reference><Citation>Sneller M.C., Liang C.J., Marques A.R., et al. A longitudinal study of COVID-19 sequelae and immunity: baseline findings. Ann. Intern. Med. 2022;Jul;175(7):969-979</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9128805</ArticleId><ArticleId IdType="pubmed">35605238</ArticleId></ArticleIdList></Reference><Reference><Citation>Rainville J.R., Hodes G.E. Inflaming sex differences in mood disorders. Neuropsychopharmacology. 2019;44:184&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6235877</ArticleId><ArticleId IdType="pubmed">29955150</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian G., Paharkova-Vatchkova V., Mao A., Nale S., Kovats S. The selective estrogen receptor modulators, tamoxifen and raloxifene, impair dendritic cell differentiation and activation. J. Immunol. 2005;175:2666&#x2013;2675.</Citation><ArticleIdList><ArticleId IdType="pubmed">16081843</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouman A., Heineman M.J., Faas M.M. Sex hormones and the immune response in humans. Hum. Reprod. Update. 2005;11:411&#x2013;423.</Citation><ArticleIdList><ArticleId IdType="pubmed">15817524</ArticleId></ArticleIdList></Reference><Reference><Citation>Albert P.R. Why is depression more prevalent in women? J. Psychiatry Neurosci. 2015;40:219&#x2013;221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4478054</ArticleId><ArticleId IdType="pubmed">26107348</ArticleId></ArticleIdList></Reference><Reference><Citation>McLean C.P., Asnaani A., Litz B.T., Hofmann S.G. Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness. J. Psychiatr. Res. 2011;45:1027&#x2013;1035.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3135672</ArticleId><ArticleId IdType="pubmed">21439576</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo S.M., Liu T.C., Motwani Y., et al. Factors associated with post-acute sequelae of SARS-CoV-2 (PASC) after diagnosis of symptomatic COVID-19 in the inpatient and outpatient setting in a diverse cohort. J. Gen. Intern. Med. 2022;Jun;37(8):1988-1995</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8989256</ArticleId><ArticleId IdType="pubmed">35391623</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelhafiz A.S., Ali A., Maaly A.M., Mahgoub M.A., Ziady H.H., Sultan E.A. Predictors of post-COVID symptoms in Egyptian patients: drugs used in COVID-19 treatment are incriminated. PLoS One. 2022;17</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8970499</ArticleId><ArticleId IdType="pubmed">35358268</ArticleId></ArticleIdList></Reference><Reference><Citation>Clift A.K., Ranger T.A., Patone M., et al. Neuropsychiatric ramifications of severe COVID-19 and other severe acute respiratory infections. JAMA Psychiatry. 2022;Jul 1;79(7):690-698</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9096686</ArticleId><ArticleId IdType="pubmed">35544272</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalcanti A.B., Zampieri F.G., Rosa R.G., et al. Hydroxychloroquine with or without azithromycin in mild-to-moderate Covid-19. N. Engl. J. Med. 2020;383:2041&#x2013;2052.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7397242</ArticleId><ArticleId IdType="pubmed">32706953</ArticleId></ArticleIdList></Reference><Reference><Citation>Group RC, Horby P., Lim W.S., et al. Dexamethasone in hospitalized patients with Covid-19. N. Engl. J. Med. 2021;384:693&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Beigel J.H., Tomashek K.M., Dodd L.E., et al. Remdesivir for the treatment of Covid-19 - final report. N. Engl. J. Med. 2020;383:1813&#x2013;1826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7262788</ArticleId><ArticleId IdType="pubmed">32445440</ArticleId></ArticleIdList></Reference><Reference><Citation>Investigators R.-C., Investigators AC-a, Investigators A, et al. Therapeutic anticoagulation with heparin in critically ill patients with Covid-19. N. Engl. J. Med. 2021;385:777&#x2013;789.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8362592</ArticleId><ArticleId IdType="pubmed">34351722</ArticleId></ArticleIdList></Reference><Reference><Citation>Investigators A., Investigators AC-a, Investigators R-C, et al. Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19. N. Engl. J. Med. 2021;385:790&#x2013;802.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8362594</ArticleId><ArticleId IdType="pubmed">34351721</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeulen R.C., Scholte H.R. Azithromycin in chronic fatigue syndrome (CFS), an analysis of clinical data. J. Transl. Med. 2006;4:34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1562448</ArticleId><ArticleId IdType="pubmed">16911783</ArticleId></ArticleIdList></Reference><Reference><Citation>Venditto V.J., Haydar D., Abdel-Latif A., et al. Immunomodulatory effects of azithromycin revisited: potential applications to COVID-19. Front. Immunol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7906979</ArticleId><ArticleId IdType="pubmed">33643308</ArticleId></ArticleIdList></Reference><Reference><Citation>Oldenburg C.E., Pinsky B.A., Brogdon J., et al. Effect of Oral azithromycin vs placebo on COVID-19 symptoms in outpatients with SARS-CoV-2 infection: a randomized clinical trial. JAMA. 2021;326:490&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8285753</ArticleId><ArticleId IdType="pubmed">34269813</ArticleId></ArticleIdList></Reference><Reference><Citation>Group PTC Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet. 2021;397:1063&#x2013;1074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7972318</ArticleId><ArticleId IdType="pubmed">33676597</ArticleId></ArticleIdList></Reference><Reference><Citation>Group RC Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2021;397:605&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7884931</ArticleId><ArticleId IdType="pubmed">33545096</ArticleId></ArticleIdList></Reference><Reference><Citation>Furtado R.H.M., Berwanger O., Fonseca H.A., et al. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial. Lancet. 2020;396:959&#x2013;967.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836431</ArticleId><ArticleId IdType="pubmed">32896292</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinks T.S.C., Cureton L., Knight R., et al. Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial. Lancet Respir. Med. 2021;9:1130&#x2013;1140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8270523</ArticleId><ArticleId IdType="pubmed">34252378</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(881&#x2013;895)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>PROMIS Meaningful Change for PROMIS [online] 2022. https://www.healthmeasures.net/score-and-interpret/interpret-scores/promis/meaningful-change Available at: Accessed May 17.</Citation></Reference><Reference><Citation>Terwee C.B., Peipert J.D., Chapman R., et al. Minimal important change (MIC): a conceptual clarification and systematic review of MIC estimates of PROMIS measures. Qual. Life Res. 2021;30:2729&#x2013;2754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8481206</ArticleId><ArticleId IdType="pubmed">34247326</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>